Location: Home
  • search
  • go
  • Relate News
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/7/2023WuXi XDC Eyes Up to $471M in Hong Kong IPO
  • 11/7/2023Bayer Join Hands with Shanghai Pharma for Its Co.Lab Incubator Network...
  • 11/7/2023Moderna Begins Construction of First China Plant during CEO's Visit fo...
  • 11/6/2023BioLineRx, GloriaBio Reach Licensing Deal for Development of Motixafor...
  • 11/6/2023486 A-Listed MedPharma Cos Report Performance in First Three Quarters ...
  • 11/6/2023JPO Publicizes 9th VBP Tender Outcome, Which Cuts Average Price by 58%
  • 11/6/2023Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
  • 11/3/2023Recent Executive Moves
  • 11/2/2023CStone, 3SBio Sign Partnership/Licensing Deal for Nofazinlimab in Main...
  • 11/2/2023NHC: 40% More Elderly Covered by Public Healthcare Services
  • 11/2/2023Report: Chinese Cities Witness Steady Health Index Increase
  • 11/1/2023NHC's Annual Statistical Report on China Healthcare Sector Development...
  • 11/1/2023Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
  • 11/1/2023Rational Vaccines and Mellow Hope Pharma Announce Collaboration to Dev...
  • 10/31/2023Financial-related Company News Digest (October 2023)
  • 10/31/2023Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
  • 10/30/2023CDE Solicits Comments on the Technical Guidelines for Stability Study ...
  • 10/30/2023Merck Group Strengthens Oncology Pipeline Thru Strategic Partnership w...
  • 10/29/2023SMEI: Chinese Terminal Drug Market Growth Rose 10.4% in H1/2023
  • 10/29/2023Coherus and Junshi Won FDA Approval of LOQTORZI (toripalimab-tpzi) for...
  • 10/29/2023Intas and Henlius Enter into Exclusive License Deal for Serplulimab in...
  • 10/29/20232023 Outlook for China's NRDL (Simon Kucher)
  • 10/25/2023Snapshot of BMI System Financial Performance in 3Qs/2023
  • 10/25/2023NMPA Issues the Guide to On-Site Inspection of Contract Manufacture by...
  • 10/25/2023Kyowa Kirin Expands Production Capacity in China
  • 10/24/2023NPC Reviews Draft Amendmets of the Infectious Disease Prevention and C...
  • 10/24/2023LianBio Enters into Agreement with BMS for Mavacamten in China and Oth...
  • 10/24/2023Medytox to Enter China's Botulinum Toxin Market with Newlux
  • 10/24/2023MIIT: Chinese Pharma Industry Up 9.3% in 14th FYP Period
  • Page:16/333 Total number of articles:9986: [First][<<] [14] [15] [16] [17] [18] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group